dragomanftgame| Xiansheng Pharmaceutical (02096): Spending HK$8.935 million to repurchase 1.565 million shares

News summary

Xiansheng Pharmaceutical (02096) adopts stock repurchase plandragomanftgame, threw 893 on May 14dragomanftgame.50,000 Hong Kong dollars, successfully attracting 156dragomanftgame.50,000 shares.

Newsletter text

[Xiansheng Pharmaceutical (02096) spent nearly HK$9 million to implement share repurchase] On May 14, 2024, Xiansheng Pharmaceutical (02096) announced that it would spend HK$8.935 million to repurchase 1.565 million shares, demonstrating the company's commitment to its own valuedragomanftgameconfidence.

This repurchase may have a positive impact on secondary market investors and raise the market's expectations for the company's future development.

Through this repurchase, Xiansheng Pharmaceutical demonstrated its strong financial strength and confidence in the company's continued growth in the future.

Tags:

Prev: bookie7slot| Guolian Securities: Acquired 100% shares of Minsheng Securities and raised 2 billion yuan in matching funds to achieve business complementarity and synergy and enhance market competitiveness
Next: cashoptionforpowerball| Sony rose more than 7.4% Q4 results exceeded expectations and announced repurchase plan of up to 250 billion yen